Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05090358
Title Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Alpelisib + Fulvestrant

Alpelisib + Canagliflozin + Fulvestrant

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Recruiting Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Recruiting Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Recruiting Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Suffolk - Commack (Limited protocol activity) Recruiting Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (All protocol Activities) Recruiting Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Weill Cornell Medical College (Data Collection & Data Analysis) Not yet recruiting New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (Limited Protocol Activities) Recruiting Uniondale New York 11553 United States Details
Ohio State University (Data Collection & Data Analysis) Not yet recruiting Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field